Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Lymphoma 6Leukemia, Lymphocytic, Chronic, B-Cell 5Melanoma 4Lymphoma, Follicular 4Lymphoma, T-Cell, Peripheral 3Lymphoma, Large B-Cell, Diffuse 3Leukemia 3Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Recurrence 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Mastocytosis, Systemic 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Mast-Cell 1Kidney Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Renal Cell 1

Interventions

Oxaliplatin 67Capecitabine 60Fluorouracil 58Bevacizumab 54Gemcitabine 51Paclitaxel 50Leucovorin 50Irinotecan 40Docetaxel 39Carboplatin 39Cisplatin 38pembrolizumab 37Nivolumab 37Cetuximab 35Sunitinib 25Trastuzumab 24Radiosurgery 24Radiotherapy 21Doxorubicin 21Cyclophosphamide 21Panitumumab 20Drug Therapy 19Pemetrexed 18Everolimus 18Sorafenib 17Interleukin-2 16Fulvestrant 16Albumin-Bound Paclitaxel 16atezolizumab 15Erlotinib Hydrochloride 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × denileukin diftitox × Clear all
NCT00299689 2014-09-05

Phase II Trial of Ontak With Metastatic Melanoma

James Graham Brown Cancer Center

Phase 2 Completed
69 enrolled 3 charts
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡